production-characterization-human-macrophages-from-pluripotent-stem

Production and Characterization of Human Macrophages from Pluripotent Stem Cells

Macrophages are present in most vertebrate tissues and comprise widely dispersed and heterogeneous cell populations with different functions. They are key ...

in-vitro-model-fetal-human-vessel-on-chip-to-study-developmental

<em>In Vitro</em> Model of Fetal Human Vessel On-chip to Study Developmental Mechanobiology

The heart is the first organ to be functionally established during development, thus initiating blood circulation very early in gestation. Besides ...

University of Edinburgh

Hematopoietic stem cell (HSC) generation in the aorta-gonad-mesonephros region requires HSC specification signals from the surrounding microenvironment. In zebrafish, PDGF-B/PDGFRβ signaling controls hematopoietic stem/progenitor cell (HSPC) generation and is required in the HSC specification niche. Little is known about murine HSPC specification in vivo and whether PDGF-B/PDGFRβ is involved. Here, we show that PDGFRβ is expressed in distinct perivascular stromal cell layers surrounding the mid-gestation dorsal aorta, and its deletion impairs hematopoiesis. We demonstrate that PDGFRβ cells play a dual role in murine hematopoiesis. They act in the aortic niche to support HSPCs, and in addition, PDGFRβ embryonic precursors give rise to a subset of HSPCs that persist into adulthood. These findings provide crucial information for the controlled production of HSPCs in vitro.

PDGFRβ cells play a dual role as hematopoietic precursors and niche cells during mouse ontogeny.

 Congenital dyserythropoietic anaemia (CDA) type IV has been associated with an amino acid substitution, Glu325Lys (E325K), in the transcription factor KLF1. These patients present with a range of symptoms, including the persistence of nucleated red blood cells (RBCs) in the peripheral blood which reflects the known role for KLF1 within the erythroid cell lineage. The final stages of RBCs maturation and enucleation take place within the erythroblastic island (EBI) niche in close association with EBI macrophages. It is not known whether the detrimental effects of the E325K mutation in KLF1 are restricted to the erythroid lineage or whether deficiencies in macrophages associated with their niche also contribute to the disease pathology.  To address this question, we generated an  model of the human EBI niche using induced pluripotent stem cells (iPSCs) derived from one CDA type IV patient as well as two iPSC lines genetically modified to express an KLF1-E325K-ER protein that could be activated with 4OH-tamoxifen. The one patient iPSC line was compared to control lines from two healthy donors and the KLF1-E325K-ER iPSC line to one inducible KLF1-ER line generated from the same parental iPSCS.  The CDA patient-derived iPSCs and iPSCs expressing the activated KLF1-E325K-ER protein showed significant deficiencies in the production of erythroid cells with associated disruption of some known KLF1 target genes. Macrophages could be generated from all iPSC lines but when the E325K-ER fusion protein was activated, we noted the generation of a slightly less mature macrophage population marked by CD93. A subtle trend in their reduced ability to support RBC enucleation was also associated with macrophages carrying the E325K-ER transgene.  Taken together these data support the notion that the clinically significant effects of the KLF1-E325K mutation are primarily associated with deficiencies in the erythroid lineage but it is possible that deficiencies in the niche might have the potential to exacerbate the condition. The strategy we describe provides a powerful approach to assess the effects of other mutations in KLF1 as well as other factors associated with the EBI niche.

Telma Ventura

Centre for Regenerative Medicine,
Scottish Centre for Regenerative Medicine,
Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine,
Institute for Regeneration and Repair,
Centre for Regenerative Medicine, Institute for Regeneration and Repair

University of Edinburgh

Production and Characterization of Human Macrophages from Pluripotent Stem Cells

In Vitro Model of Fetal Human Vessel On-chip to Study Developmental Mechanobiology

Telma Ventura

Centre for Regenerative Medicine,Scottish Centre for Regenerative Medicine,Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine,Institute for Regeneration and Repair,Centre for Regenerative Medicine, Institute for Regeneration and Repair

University of Edinburgh

Production and Characterization of Human Macrophages from Pluripotent Stem Cells

In Vitro Model of Fetal Human Vessel On-chip to Study Developmental Mechanobiology

Centre for Regenerative Medicine,
Scottish Centre for Regenerative Medicine,
Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine,
Institute for Regeneration and Repair,
Centre for Regenerative Medicine, Institute for Regeneration and Repair